• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

173352-39-1 (Fabomotizole (hydrochloride))

1

Identification

Fabomotizole (hydrochloride) Fabomotizole (hydrochloride)
Name Fabomotizole (hydrochloride)
Formula C15H22ClN3O2S
MW 343.8721
CAS No. 173352-39-1
EINECS
Smiles CCOC1=CC=C2C(N=C(SCCN3CCOCC3)N2)=C1.Cl
Synonyms CM346 hydrochloride
InChI InChI=1S/C15H21N3O2S.ClH/c1-2-20-12-3-4-13-14(11-12)17-15(16-13)21-10-7-18-5-8-19-9-6-18;/h3-4,11H,2,5-10H2,1H3,(H,16,17);1H
2

Introduction

Background Information

Fabomotizole (brand name Afobazole) is an anxiolytic drug launched in Russia in the early 2000s. It produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions. Its mechanism of action remains poorly defined however, wi ......by BOC Sciences
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance:Light yellow to yellow Solid EBNumber:EB000010068

Storage condition

Solubility

5

Mechanism and Indication

Signaling Pathways Others
Target Others
Research Area Neurological Disease
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
Fabomotizole (hydrochloride) - Launched
7

Safety Data of Fabomotizole (hydrochloride)

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
BOC Sciences
CHEMSCENE, LLC 5mg/USD420();10mg/USD600() USA
Lancrix Chemicals. 10mg/USD450() China
MedChemexpress Co., Ltd. 5mg/USD420();10mg/USD600() USA
Shanghai Haoyuan Chemexpress Co., Ltd. 5mg/USD420();10mg/USD600() China
10

Related Products

Other Forms of 173352-39-1

Name CAS No Formula MW
Fabomotizole 173352-21-1 C15H21N3O2S 307.4111

Recommended Compounds in Others

Name CAS No Formula MW
(R)-(+)-Etomoxir (sodium salt) 828934-41-4 C15H18ClNaO4 320.74
Dictamine 484-29-7 C12H9NO2 199.21
3,3',5-Triiodo-L-thyronine (sodium) 55-06-1 C15H11I3NNaO4 672.9553
FPH2 957485-64-2 C14H16ClN5O2S 353.83
α-Tocopherol (phosphate) 38976-17-9 C29H51O5P 510.69
BAMB-4 891025-25-5 C15H12N2O2 252.27
LDN-27219 312946-37-5 C20H16N4O2S2 408.5
ISO-1 478336-92-4 C12H13NO4 235.24
Aurothioglucose 12192-57-3 C6H11AuO5S 392.18
Oxybenzone 131-57-7 C14H12O3 228.24
ITX3 347323-96-0 C22H17N3OS 371.45
Cardiogreen 3599-32-4 C43H47N2NaO6S2 774.96
Skp2 Inhibitor C1 432001-69-9 C18H13BrN2O4S2 465.34
INH1 313553-47-8 C18H16N2OS 308.4
PF6-AM 1268491-69-5 C33H31BO12 630.4
XEN445 1515856-92-4 C18H17F3N2O3 366.33
Disperse Blue 148 52239-04-0 C19H19N5O4S 413.45026
Solvent Blue 35 17354-14-2 C22H26N2O2 350.454
CID-797718 370586-05-3 C12H11NO3 217.2206
CP-640186 (hydrochloride) 591778-70-0 C30H36ClN3O3 522.08

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

[1]. Afobazole, From Wikipedia

Protocol Reference

13

More Information

Fabomotizole (hydrochloride)

Tags: buy 173352-39-1 IC50 | 173352-39-1 price | 173352-39-1 cost | 173352-39-1 solubility | 173352-39-1 purchase | 173352-39-1 manufacturer | 173352-39-1 research buy | 173352-39-1 order | 173352-39-1 MSDS | 173352-39-1 chemical structure | 173352-39-1 Storage condition | 173352-39-1 molecular weight | 173352-39-1 mw | 173352-39-1 datasheet | 173352-39-1 supplier | 173352-39-1 cell line | 173352-39-1 NMR | 173352-39-1 MS | 173352-39-1 IR | 173352-39-1 solubility | 173352-39-1 Safe information | 173352-39-1 Qc and Spectral Information | 173352-39-1 Clinical Information | 173352-39-1 Clinical Trial | 173352-39-1 Route of Synthesis | 173352-39-1 storage condition | 173352-39-1 diseases and conditions | 173352-39-1 flash point | 173352-39-1 boiling point | 173352-39-1 melting point | 173352-39-1 storage condition | 173352-39-1 brand